"Pioglitazone Slows Progression to Type 2 Diabetes: More IRIS Data"


Pioglitazone Slows Progression to Type 2 Diabetes: More IRIS Data

"Pioglitazone halved the progression to diabetes in people with insulin resistance and cerebrovascular disease, new data from the Insulin Resistance Intervention after Stroke (IRIS) trial show."

Click here to read the full article

Source- http://www.medscape.com/viewarticle/864986

#Pioglitazone #Insulinresistance #Type2diabetes #news

Must Read